More on MRK

- Summary
- Chart
- Profile
- Historical


- Earnings (-6.7% Growth)
- Ratings (7.1 Score)
- Holders
- Dividends (3.3% Yield)
- Event Driven Deals
- FDA Archive


Income Statement
Balance Sheet
Cash Flow Statement

Upcoming Events

- Earnings (8/2/21 *Est.)
- M&A (6/30/19 *Est)
- M&A (6/30/21 *Est)


- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks

MRK Income Statement

Click line-items for a historical chart and %
Sales 23.64B
Costs, Expenses and Other
Materials and production 5.59B
Marketing and administrative 7.32B
Research and development 5.14B
Restructuring costs 545.6M
Equity income from affiliates -2.5B
Other (income) expense, net -3.28B
Total Costs, Expenses and Other 12.82B
Income Before Taxes 10.82B
Taxes on Income 2.75B
Net Income 8.08B
Less: Net Income Attributable to Noncontrolling Interests 122.8M
Net Income Attributable to Merck & Co., Inc. 7.95B
Basic Earnings per Common Share Attributable to Merck & Co., Inc. Common Shareholders
Earnings per Common Share Assuming Dilution Attributable to Merck & Co., Inc. Common Shareholders
Dividends Declared per Common Share